Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123068324 | 12306832 | 4 | F | 20140524 | 20160908 | 20160426 | 20160915 | EXP | US-BAYER-2016-033205 | BAYER | 82.00 | YR | E | F | Y | 0.00000 | 20160915 | LW | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123068324 | 12306832 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 10 MG, UNK | Y | N | UNKNOWN;UNKNOWN | 0 | 10 | MG | FILM-COATED TABLET | ||||
| 123068324 | 12306832 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20 MG, UNK | Y | N | UNKNOWN;UNKNOWN | 0 | 20 | MG | FILM-COATED TABLET | ||||
| 123068324 | 12306832 | 3 | SS | XARELTO | RIVAROXABAN | 1 | Y | N | 0 | FILM-COATED TABLET | |||||||||
| 123068324 | 12306832 | 4 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | UNK | 0 | ||||||||||
| 123068324 | 12306832 | 5 | PS | ACETYLSALICYLIC ACID({=100 mg) | ASPIRIN | 1 | Unknown | UNK | U | 999999 | |||||||||
| 123068324 | 12306832 | 6 | C | GLIPIZIDE. | GLIPIZIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 123068324 | 12306832 | 7 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | UNK | 0 | ||||||||||
| 123068324 | 12306832 | 8 | C | ATENOLOL. | ATENOLOL | 1 | Unknown | UNK | 0 | ||||||||||
| 123068324 | 12306832 | 9 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Unknown | UNK | 0 | ||||||||||
| 123068324 | 12306832 | 10 | C | COZAAR | LOSARTAN POTASSIUM | 1 | Unknown | UNK | 0 | ||||||||||
| 123068324 | 12306832 | 11 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 123068324 | 12306832 | 12 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 25 MG, UNK | 0 | 25 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123068324 | 12306832 | 1 | Atrial fibrillation |
| 123068324 | 12306832 | 2 | Thrombosis prophylaxis |
| 123068324 | 12306832 | 3 | Cerebrovascular accident prophylaxis |
| 123068324 | 12306832 | 4 | Coronary artery disease |
| 123068324 | 12306832 | 5 | Product used for unknown indication |
| 123068324 | 12306832 | 6 | Diabetes mellitus |
| 123068324 | 12306832 | 7 | Gout |
| 123068324 | 12306832 | 8 | Product used for unknown indication |
| 123068324 | 12306832 | 9 | Product used for unknown indication |
| 123068324 | 12306832 | 10 | Product used for unknown indication |
| 123068324 | 12306832 | 11 | Product used for unknown indication |
| 123068324 | 12306832 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123068324 | 12306832 | DE |
| 123068324 | 12306832 | HO |
| 123068324 | 12306832 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123068324 | 12306832 | Death | |
| 123068324 | 12306832 | Epistaxis | |
| 123068324 | 12306832 | Gastrointestinal haemorrhage | |
| 123068324 | 12306832 | Haemorrhagic stroke |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123068324 | 12306832 | 1 | 20140430 | 20140524 | 0 | |
| 123068324 | 12306832 | 2 | 2014 | 201408 | 0 | |
| 123068324 | 12306832 | 4 | 2008 | 2014 | 0 | |
| 123068324 | 12306832 | 6 | 2008 | 20140905 | 0 | |
| 123068324 | 12306832 | 7 | 2007 | 2008 | 0 | |
| 123068324 | 12306832 | 8 | 2010 | 20140905 | 0 |